Research Article

Establishment and Validation for Predicting the Lymph Node Metastasis in Early Gastric Adenocarcinoma

Table 1

Characteristics of all patients.

VariablesClinical data (n = 494)SEER data
Total (n = 842)Training set (n = 505)Test set (n = 337)

Age (years), mean ± SD53.80 ± 10.6069.4 ± 11.369.05 ± 11.7669.80 ± 10.71

Gender, n (%)
Female218 (44.13)357 (42.40)214 (42.38)143 (42.43)
Male276 (55.87)485 (57.60)291 (57.62)194 (57.57)

T stage, n (%)
T1a243 (49.19)306 (36.34)176 (34.85)130 (38.58)
T1b251 (50.81)536 (63.66)329 (65.15)207 (61.42)

Primary site, n (%)
Overlap13 (2.63)59 (7.01)41 (8.12)18 (5.34)
Lower348 (70.45)455 (54.04)267 (52.87)188 (55.79)
Middle120 (24.29)303 (35.99)185 (36.63)118 (35.01)
Upper13 (2.63)25 (2.97)12 (2.38)13 (3.86)

Type, n (%)
Diffuse302 (61.13)69 (8.19)36 (7.13)33 (9.79)
Intestinal16 (3.24)700 (83.14)424 (83.96)276 (81.90)
Others176 (35.63)73 (8.67)45 (8.91)28 (8.31)

Tumor size (cm), n (%)
1-130 (26.32)148 (17.58)135 (26.73)110 (32.64)
2-151 (30.57)245 (29.10)117 (23.17)57 (16.91)
3-122 (24.70)174 (20.67)60 (11.88)53 (15.73)
4-57 (11.54)113 (13.42)101 (20.00)61 (18.10)
<134 (6.88)162 (19.24)92 (18.22)56 (16.62)

Grade, n (%)
I314 (63.56)143 (16.98)78 (15.45)65 (19.29)
II128 (25.91)334 (39.67)206 (40.79)128 (37.98)
III52 (10.53)365 (43.35)221 (43.76)144 (42.73)

LNM, n (%)
No361 (73.08)666 (79.10)398 (78.81)268 (79.53)
Yes133 (26.92)176 (20.90)107 (21.19)69 (20.47)

Note: LNM: lymph node metastasis.